Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of Venous Leg Ulcers (VALUE)

NCT06568627 is registered in ClinicalTrials.gov with MediWound Ltd as lead sponsor.

NCT NCT06568627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06568627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of Venous Leg Ulcers (VALUE)
Lead sponsor
MediWound Ltd
Phase
Phase 3
Overall status
Recruiting
Start date
June 1, 2025
Completion date
March 31, 2027
Enrollment
216 (estimated)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

venous leg ulcer (vlu)